scholarly article | Q13442814 |
P356 | DOI | 10.1158/0008-5472.CAN-10-3504 |
P8608 | Fatcat ID | release_uko7okhu25cd7i4bk7j2fvosk4 |
P932 | PMC publication ID | 3117049 |
P698 | PubMed publication ID | 21555369 |
P50 | author | Mien-Chie Hung | Q1532952 |
Huang-Chun Lien | Q57615108 | ||
Yuh-Pyng Sher | Q96019062 | ||
Ying-Nai Wang | Q125292987 | ||
Haou-Tzong Ma | Q125293348 | ||
P2093 | author name string | Long-Yuan Li | |
Chang-Hai Tsai | |||
Chien-Chen Lai | |||
Ya-Huey Chen | |||
Yi-Hsien Hsieh | |||
Hui-Yu Chen | |||
Hsiao-Ju Chu | |||
Peng-Ju Chien | |||
Ho-Cheng Tsai | |||
Hsiuyi Chen | |||
P2860 | cites work | Endosomal transport of ErbB-2: mechanism for nuclear entry of the cell surface receptor | Q24297204 |
Tyrosine phosphorylation controls PCNA function through protein stability | Q24317732 | ||
Identification of heregulin, a specific activator of p185erbB2 | Q24338146 | ||
Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway | Q24650927 | ||
gamma -Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase | Q28202328 | ||
Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain | Q28266755 | ||
Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2 | Q28283279 | ||
The EGF receptor family: spearheading a merger of signaling and therapeutics | Q28289369 | ||
Does the ribosome translate cancer? | Q29618775 | ||
EGF-ERBB signalling: towards the systems level | Q29619032 | ||
Dysregulation of ribosome biogenesis and translational capacity is associated with tumor progression of human breast cancer cells. | Q33506633 | ||
Nuclear trafficking of the epidermal growth factor receptor family membrane proteins | Q33998459 | ||
RNA helicase A is a DNA-binding partner for EGFR-mediated transcriptional activation in the nucleus | Q34136636 | ||
Nuclear actin and myosin I are required for RNA polymerase I transcription. | Q34370248 | ||
Actin and myosin as transcription factors | Q34496916 | ||
Molecular functions of nuclear actin in transcription | Q34503691 | ||
RNA polymerases I and III, non-coding RNAs and cancer | Q34599662 | ||
The RNA polymerase I transcription machinery: an emerging target for the treatment of cancer | Q34615483 | ||
RNA polymerases I and III, growth control and cancer | Q36028214 | ||
Actin and myosin I in the nucleus: what next? | Q36248896 | ||
Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival. | Q36376782 | ||
c-Myc enhances protein synthesis and cell size during B lymphocyte development | Q36668198 | ||
Nuclear expression of epidermal growth factor receptor is a novel prognostic value in patients with ovarian cancer | Q37282661 | ||
Growth control and ribosome biogenesis. | Q37606782 | ||
Nuclear translocation of the epidermal growth factor receptor family membrane tyrosine kinase receptors | Q37622619 | ||
Translational control in cancer. | Q37717999 | ||
MYC as a regulator of ribosome biogenesis and protein synthesis | Q37718002 | ||
Nuclear myosin I acts in concert with polymeric actin to drive RNA polymerase I transcription | Q40019177 | ||
Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth | Q40357721 | ||
Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis | Q40395185 | ||
Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells. | Q40453819 | ||
Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer. | Q40467153 | ||
Nuclear localization of EGF receptor and its potential new role as a transcription factor | Q40782527 | ||
Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency | Q40890351 | ||
Nuclear localization of p185neu tyrosine kinase and its association with transcriptional transactivation | Q41441273 | ||
A ligand for the erbB-2 oncogene product (gp30) induces differentiation of human breast cancer cells | Q41616911 | ||
The Myc trilogy: lord of RNA polymerases. | Q52655658 | ||
Nuclear EGFR in ductal invasive breast cancer: correlation with cyclin-D1 and prognosis. | Q54699349 | ||
Expression and Nuclear Localization of ErbB3 in Prostate Cancer | Q58325229 | ||
The developing role of receptors and adaptors | Q83150764 | ||
Nuclear expression of phosphorylated EGFR is associated with poor prognosis of patients with esophageal squamous cell carcinoma | Q95788188 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell growth | Q189159 |
Erb-b2 receptor tyrosine kinase 2 | Q415271 | ||
positive regulation of transcription by RNA polymerase I | Q14877482 | ||
P304 | page(s) | 4269-4279 | |
P577 | publication date | 2011-05-09 | |
P1433 | published in | Cancer Research | Q326097 |
P1476 | title | Nuclear ErbB2 enhances translation and cell growth by activating transcription of ribosomal RNA genes | |
P478 | volume | 71 |
Q39033771 | A targeting modality for destruction of RNA polymerase I that possesses anticancer activity. |
Q61805825 | AKT/protein kinase B associates with β-actin in the nucleus of melanoma cells |
Q38897153 | Binding of carbonic anhydrase IX to 45S rDNA genes is prevented by exportin-1 in hypoxic cells |
Q40234876 | Bioinspired peptosomes with programmed stimuli-responses for sequential drug release and high-performance anticancer therapy |
Q36938534 | Biological function of nuclear receptor tyrosine kinase action |
Q98726033 | Canonical ErbB-2 isoform and ErbB-2 variant c located in the nucleus drive triple negative breast cancer growth |
Q28542825 | Comparative analysis of evolutionarily conserved motifs of epidermal growth factor receptor 2 (HER2) predicts novel potential therapeutic epitopes |
Q38244150 | Compartmentalization of TNF-related apoptosis-inducing ligand (TRAIL) death receptor functions: emerging role of nuclear TRAIL-R2. |
Q41945151 | Extreme multifunctional proteins identified from a human protein interaction network. |
Q28383407 | HER2 confers drug resistance of human breast cancer cells through activation of NRF2 by direct interaction |
Q33737278 | HER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance |
Q35831012 | Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations |
Q35956440 | Membrane-bound trafficking regulates nuclear transport of integral epidermal growth factor receptor (EGFR) and ErbB-2. |
Q26773754 | Non-canonical signaling mode of the epidermal growth factor receptor family |
Q36920432 | Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer |
Q36497514 | Nuclear actin and myosins at a glance |
Q36162605 | Nuclear functions and subcellular trafficking mechanisms of the epidermal growth factor receptor family |
Q52353881 | PDGFRβ translocates to the nucleus and regulates chromatin remodeling via TATA element-modifying factor 1. |
Q36113481 | Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases |
Q26830216 | Receptor tyrosine kinases in the nucleus |
Q37151063 | Ribosomal RNA gene transcription mediated by the master genome regulator protein CCCTC-binding factor (CTCF) is negatively regulated by the condensin complex |
Q43203015 | Significant association of YAP1 and HSPC111 proteins with poor prognosis in Chinese gastric cancer patients |
Q38849205 | Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis. |
Q47282308 | Suppression of Kpnβ1 expression inhibits human breast cancer cell proliferation by abrogating nuclear transport of Her2. |
Q37417599 | Syntaxin 6-mediated Golgi translocation plays an important role in nuclear functions of EGFR through microtubule-dependent trafficking |
Q55071512 | Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance. |
Q92702770 | The NAE Pathway: Autobahn to the Nucleus for Cell Surface Receptors |
Q38124258 | The emerging role of RNA polymerase I transcription machinery in human malignancy: a clinical perspective. |
Q46293920 | The nuclear mitotic apparatus protein NuMA controls rDNA transcription and mediates the nucleolar stress response in a p53-independent manner. |
Q49580495 | Translocation of Epidermal Growth Factor (EGF) to the nucleus has distinct kinetics between adipose tissue-derived mesenchymal stem cells and a mesenchymal cancer cell lineage |
Search more.